tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

APLM Stock Latest News

Apollomics price target lowered to $2 from $5 at H.C. Wainwright
The FlyApollomics price target lowered to $2 from $5 at H.C. Wainwright
13d ago
APLM
Apollomics announces approval of vebreltinib in China
PremiumThe Fly
Apollomics announces approval of vebreltinib in China
26d ago
APLM
Apollomics presents vebreltinib data at AACR meeting
PremiumThe Fly
Apollomics presents vebreltinib data at AACR meeting
1M ago
APLM
Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
PremiumPress Releases
Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
1M ago
APLM
Apollomics price target lowered to $5 from $17 at H.C. Wainwright
PremiumThe Fly
Apollomics price target lowered to $5 from $17 at H.C. Wainwright
2M ago
APLM
Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results
PremiumPress ReleasesApollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results
2M ago
APLM
Apollomics reports FY23 EPS ($2.32) vs ($8.44) last year
PremiumThe Fly
Apollomics reports FY23 EPS ($2.32) vs ($8.44) last year
2M ago
APLM
Apollomics appoints Plunkett as CFO
PremiumThe Fly
Apollomics appoints Plunkett as CFO
3M ago
APLM
Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer
PremiumPress Releases
Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer
3M ago
APLM
Apollomics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PremiumPress Releases
Apollomics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
3M ago
APLM
Apollomics receives Nasdaq notification regarding minimum bid price
PremiumThe Fly
Apollomics receives Nasdaq notification regarding minimum bid price
4M ago
APLM
Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
PremiumPress Releases
Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
4M ago
APLM
Apollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference
PremiumPress ReleasesApollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference
4M ago
APLM
Apollomics completes enrollment in Phase 3 bridging study of APL-106
PremiumThe Fly
Apollomics completes enrollment in Phase 3 bridging study of APL-106
5M ago
APLM
GLYC
Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
PremiumPress Releases
Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
5M ago
APLM
Apollomics to Present at the 2024 Biotech Showcase
PremiumPress Releases
Apollomics to Present at the 2024 Biotech Showcase
5M ago
APLM
Apollomics presents interim data from ongoing Phase 2 trials with vebreltinib
PremiumThe Fly
Apollomics presents interim data from ongoing Phase 2 trials with vebreltinib
6M ago
APLM
Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
PremiumPress Releases
Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
6M ago
APLM
Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC)
PremiumPress Releases
Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC)
6M ago
APLM
EF Hutton keeps $11 target on Apollomics after ‘very positive’ news
PremiumThe FlyEF Hutton keeps $11 target on Apollomics after ‘very positive’ news
6M ago
APLM
Apollomics announces first approval of vebreltinib for MET Exon 14 skip NSCLC
PremiumThe Fly
Apollomics announces first approval of vebreltinib for MET Exon 14 skip NSCLC
6M ago
APLM
Apollomics Announces the First Approval of Vebreltinib for MET Exon 14 Skip Non-Small Cell Lung Cancer
PremiumPress Releases
Apollomics Announces the First Approval of Vebreltinib for MET Exon 14 Skip Non-Small Cell Lung Cancer
6M ago
APLM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >